• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2015 - 2017年期间巴勒斯坦约旦河西岸戊型肝炎病毒血清流行率及危险因素评估的首次报告

First Report of the HEV Seroprevalence and the Risk Factor Assessment in the West Bank, Palestine, during the Period of 2015-2017.

作者信息

Dumaidi Kamal, Abudamous Alaa M, Abu-Helu Rasmi, Al-Jawabreh Hanan, Dumaidi Yazan, Al-Jawabreh Amer

机构信息

Department of Medical Laboratory Sciences, Faculty of Allied Health Sciences, Arab American University Palestine, Jenin, State of Palestine.

Al-Quds Primary Health Care, Palestinian Ministry of Health, Ramallah, State of Palestine.

出版信息

Can J Infect Dis Med Microbiol. 2022 Feb 8;2022:4935811. doi: 10.1155/2022/4935811. eCollection 2022.

DOI:10.1155/2022/4935811
PMID:35178134
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8847015/
Abstract

Hepatitis E virus is emerging viral hepatitis with hyperendemicity in many countries. Data on the burden of disease is not available in Palestine. This study aims to determine the seroprevalence and the risk factors of the HEV among the general population of the West Bank, Palestine. In this cross-sectional study, a total of 432 sera samples from 40 localities in the eleven districts of the West Bank and Jerusalem, Palestine, during the period of March 2015 to March 2017, were tested for HEV-IgG. A structured questionnaire was used to collect data of the participants' demographics and disease risk factors. The overall seroprevalence was 3.7%. Level of education was significantly inversely associated with HEV seropositivity (=0.04). Purely spatial analysis did not detect any significant cluster related to the distribution of HEV-IgG cases; however, living in the southern West Bank is shown to be significantly associated with HEV. Age was also associated with HEV seropositivity. The young (<19 years) and adults (>40 years) had the highest prevalence, compared to those between 20 to 39 years old (=0.12). Furthermore, males and those in contact with animals were associated with HEV seropositivity (=0.1 and 0.3, respectively). In conclusion, the seroprevalence of HEV IgG in the West Bank, Palestine is low. Several well-investigated risk factors cannot be supported by our results due to the small number of the positive HEV-IgG samples. Finally, this study is useful for providing a first look into the seroepidemiology of HEV in Palestine.

摘要

戊型肝炎病毒是一种在许多国家呈高度地方性流行的新发病毒性肝炎。巴勒斯坦尚无关于该疾病负担的数据。本研究旨在确定巴勒斯坦约旦河西岸普通人群中戊型肝炎病毒的血清流行率及其危险因素。在这项横断面研究中,于2015年3月至2017年3月期间,对来自巴勒斯坦约旦河西岸和耶路撒冷11个区40个地点的432份血清样本进行了戊型肝炎病毒IgG检测。使用结构化问卷收集参与者的人口统计学数据和疾病危险因素。总体血清流行率为3.7%。教育程度与戊型肝炎病毒血清阳性呈显著负相关(P = 0.04)。单纯的空间分析未检测到与戊型肝炎病毒IgG病例分布相关的任何显著聚集情况;然而,居住在约旦河西岸南部与戊型肝炎病毒感染显著相关。年龄也与戊型肝炎病毒血清阳性有关。与20至39岁的人群相比,年轻人(<19岁)和成年人(>40岁)的患病率最高(P = 0.12)。此外,男性以及与动物有接触的人也与戊型肝炎病毒血清阳性有关(P分别为0.1和0.3)。总之,巴勒斯坦约旦河西岸戊型肝炎病毒IgG的血清流行率较低。由于戊型肝炎病毒IgG阳性样本数量较少,我们的结果无法支持几个经过充分研究的危险因素。最后,本研究有助于初步了解巴勒斯坦戊型肝炎病毒的血清流行病学情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5946/8847015/437e9069f120/CJIDMM2022-4935811.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5946/8847015/437e9069f120/CJIDMM2022-4935811.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5946/8847015/437e9069f120/CJIDMM2022-4935811.001.jpg

相似文献

1
First Report of the HEV Seroprevalence and the Risk Factor Assessment in the West Bank, Palestine, during the Period of 2015-2017.2015 - 2017年期间巴勒斯坦约旦河西岸戊型肝炎病毒血清流行率及危险因素评估的首次报告
Can J Infect Dis Med Microbiol. 2022 Feb 8;2022:4935811. doi: 10.1155/2022/4935811. eCollection 2022.
2
Seroprevalence for hepatitis E virus (HEV) infection among volunteer blood donors of the Regional Blood Bank of Londrina, State of Paraná , Brazil.巴西巴拉那州隆德里纳地区血库志愿献血者中戊型肝炎病毒(HEV)感染的血清流行率。
Rev Inst Med Trop Sao Paulo. 2006 Mar-Apr;48(2):87-92. doi: 10.1590/s0036-46652006000200006. Epub 2006 May 8.
3
Hepatitis E virus seroprevalence among the general population in a livestock-dense area in the Netherlands: a cross-sectional population-based serological survey.荷兰一个牲畜密集地区普通人群中的戊型肝炎病毒血清流行率:一项基于人群的横断面血清学调查。
BMC Infect Dis. 2017 Jan 5;17(1):21. doi: 10.1186/s12879-016-2160-4.
4
Prevalence of Hepatitis E Virus among Adults in South-West of Iran.伊朗西南部成年人中戊型肝炎病毒的流行情况
Hepat Res Treat. 2015;2015:759589. doi: 10.1155/2015/759589. Epub 2015 Jun 23.
5
[Investigation of the hepatitis E virus seroprevalence in cases admitted to Hacettepe University Medical Faculty Hospital].[对哈杰泰佩大学医学院附属医院收治病例中戊型肝炎病毒血清流行率的调查]
Mikrobiyol Bul. 2015 Oct;49(4):554-64. doi: 10.5578/mb.9881.
6
Seroprevalence of hepatitis E virus differs in Dutch and first generation migrant populations in Amsterdam, the Netherlands: a cross-sectional study.荷兰阿姆斯特丹荷兰人和第一代移民人群中戊型肝炎病毒血清流行率存在差异:一项横断面研究。
BMC Infect Dis. 2016 Nov 8;16(1):659. doi: 10.1186/s12879-016-2007-z.
7
Seroprevalence and risk factors of Hepatitis E infection in Jordan's population: First report.约旦人群的戊型肝炎血清流行率和感染因素:首次报告。
Int J Infect Dis. 2018 Jan;66:121-125. doi: 10.1016/j.ijid.2017.11.015. Epub 2017 Nov 13.
8
Seroprevalence of Hepatitis E Virus Antibodies in Portuguese Children.葡萄牙儿童戊型肝炎病毒抗体血清流行率
Pediatr Infect Dis J. 2017 Jul;36(7):623-626. doi: 10.1097/INF.0000000000001525.
9
Relative risk factors for seropositive hepatitis E virus among blood donors and haemodialysis patients: The pivotal role of primary health care education.献血者和血液透析患者中戊型肝炎病毒血清阳性的相关风险因素:初级卫生保健教育的关键作用。
J Family Med Prim Care. 2021 Jul;10(7):2655-2660. doi: 10.4103/jfmpc.jfmpc_2441_20. Epub 2021 Jul 30.
10
Seroepidemiology of hepatitis E in patients on haemodialysis in Croatia.克罗地亚血液透析患者戊型肝炎血清流行病学。
Int Urol Nephrol. 2020 Feb;52(2):371-378. doi: 10.1007/s11255-019-02363-3. Epub 2020 Jan 1.

引用本文的文献

1
Seroprevalence of Hepatitis E Virus Infection in Middle Eastern Countries: A Systematic Review and Meta-Analysis.中东国家戊型肝炎病毒感染的血清流行率:系统评价和荟萃分析。
Medicina (Kaunas). 2022 Jul 6;58(7):905. doi: 10.3390/medicina58070905.

本文引用的文献

1
The Prevalence of Hepatitis E Virus Infection in the Adult Turkish Population: A Systematic Review of the Literature and Prevalence Study in Blood Donors in Mersin Province.戊型肝炎病毒在土耳其成人人群中的感染率:文献系统评价和梅尔辛省献血者中的流行率研究。
Turk J Gastroenterol. 2021 Sep;32(9):782-789. doi: 10.5152/tjg.2021.20870.
2
Hepatitis E in Bangladesh: Insights From a National Serosurvey.孟加拉国的戊型肝炎:一项全国血清学调查的启示。
J Infect Dis. 2021 Dec 20;224(12 Suppl 2):S805-S812. doi: 10.1093/infdis/jiab446.
3
Hepatitis E Virus Infection and Butchers: A Case-Control Seroprevalence Study.
戊型肝炎病毒感染与屠夫:一项病例对照血清学患病率研究。
Gastroenterology Res. 2021 Apr;14(2):96-103. doi: 10.14740/gr1198. Epub 2021 Apr 21.
4
Seroprevalence of Hepatitis E Virus Infection among Blood Donors in Bulgaria.保加利亚献血者中戊型肝炎病毒感染的血清流行率。
Viruses. 2021 Mar 16;13(3):492. doi: 10.3390/v13030492.
5
Autochthonous and Travel Acquired Hepatitis E Virus in Australia.澳大利亚的本土和旅行获得性戊型肝炎病毒
Front Microbiol. 2021 Feb 4;12:640325. doi: 10.3389/fmicb.2021.640325. eCollection 2021.
6
An outbreak of hepatitis E in Yavatmal, India, 2019.印度亚瓦特马尔 2019 年戊型肝炎爆发。
J Med Virol. 2021 Jun;93(6):3761-3768. doi: 10.1002/jmv.26377. Epub 2020 Oct 25.
7
Seroprevalence of hepatitis E virus antibodies in adults and children from upstate New York: A cross-sectional study.纽约州北部成年人和儿童的戊型肝炎病毒抗体血清流行率:一项横断面研究。
PLoS One. 2021 Jan 26;16(1):e0245850. doi: 10.1371/journal.pone.0245850. eCollection 2021.
8
Clinical Outcomes and Prevalence of Hepatitis E Virus (HEV) Among Non-A-C Hepatitis Patients in Egypt.埃及非甲非戊型肝炎患者中戊型肝炎病毒(HEV)的临床结局与流行情况
Infect Drug Resist. 2021 Jan 12;14:59-69. doi: 10.2147/IDR.S289766. eCollection 2021.
9
A systematic review of the epidemiology of Hepatitis E virus infection in South - Eastern Asia.东南亚戊型肝炎病毒感染的流行病学系统评价。
Virulence. 2021 Dec;12(1):114-129. doi: 10.1080/21505594.2020.1865716.
10
Hepatitis E virus genotype 1f outbreak in Bangladesh, 2018.2018 年孟加拉国戊型肝炎病毒 1f 基因型暴发。
J Med Virol. 2021 Aug;93(8):5177-5181. doi: 10.1002/jmv.26739. Epub 2020 Dec 29.